Table 1.
Summary of demographic and clinical values for patients with VSS.
| Non-visual symptoms | Visual symptoms | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patients | Age (years) | Sex | Migraine | With aura | Tinnitus | Depression | Anxiety | Duration of VS (years) | Imbalance | Palinopsia | Blue field entoptic phenomenon | Other entoptic phenomena | Photophobia | Glare | Nyctalopia |
| P1 | 44 | 0 | 1 | 0 | 1 | 0 | 0 | 9.0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| P2 | 47 | 1 | 1 | 1 | 1 | 1 | 0 | 17.0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 |
| P3 | 23 | 1 | 0 | 0 | 0 | 1 | 0 | 5.5 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
| P4 | 33 | 1 | 0 | 0 | 1 | 0 | 1 | 4.2 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
| P5 | 18 | 1 | 0 | 0 | 1 | 1 | 1 | 1.0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 |
| P6 | 19 | 1 | 0 | 0 | 1 | 0 | 0 | 19.3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| P7 | 44 | 0 | 1 | 1 | 0 | 1 | 1 | 4.1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 |
| P8 | 30 | 0 | 1 | 1 | 1 | 0 | 0 | 4.9 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
| P9 | 39 | 0 | 1 | 1 | 1 | 0 | 1 | 0.8 | 0 | 0 | 1 | 0 | 1 | 1 | 1 |
| P10 | 33 | 1 | 0 | 0 | 0 | 0 | 0 | 2.0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 |
| P11 | 21 | 1 | 1 | 1 | 1 | 0 | 0 | 1.2 | 1 | 1 | 0 | 1 | 0 | 1 | 0 |
| P12 | 54 | 0 | 1 | 1 | 1 | 1 | 0 | 0.6 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
| P13 | 22 | 1 | 0 | 0 | 1 | 0 | 0 | 6.0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| P14 | 30 | 1 | 0 | 0 | 0 | 0 | 0 | 5.0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 |
For sex, 1 = male, 0 = female. For all other variables, 1 = present, 0 = absent. Six of seven patients with migraine demonstrated visual aura.